Hemoglobinopathies (Sickle Cell Disease and Thalassemia)
- PMID: 32091749
- Bookshelf ID: NBK553928
- DOI: 10.1007/978-3-030-02278-5_79
Hemoglobinopathies (Sickle Cell Disease and Thalassemia)
Excerpt
Sickle cell disease (SCD) is the most common inherited hemoglobinopathy worldwide.
Copyright 2019, EBMT and the Author(s).
References
-
- Andreani M, Nesci S, Lucarelli G, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. 2000;25:401–4. - PubMed
-
- Angelucci E, Matthes-Martin S, Baronciani D, et al. EBMT Inborn Error and EBMT Paediatric Working Parties. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica. 2014;99:811–20. - PMC - PubMed
-
- Angelucci E, Pilo F, Coates TD. Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later. Am J Hematol. 2017;92:411–3. - PubMed
-
- Arnold SD, Bhatia M, Horan J, Krishnamurti L. Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches. Br J Haematol. 2016;174:515–25. - PubMed
-
- Baronciani D, Angelucci E, Potschger U, et al. Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transplant. 2016;51:536–41. - PubMed
Publication types
LinkOut - more resources
Full Text Sources